Physicians
Beacon lights path to FDA approval with pivotal trial win for rare vision loss gene therapy
- Beacon Therapeutics has found the light in a rare vision loss disease that has left larger companies in the dark. The biotech’s gene therapy for X-linked retinitis pigmentosa (XLRP) successfully improved visual acuity in
